⚕ GalenOps CRO console
← 708 (USA)

708-1336

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 708 (USA) (Dr. Kim) · consented 2012-12-07
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-10 (study day 125.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2013-04-10 (study day 125.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-01-12 (study day 37.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-10 (study day 125.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-04-10 (study day 125.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2012-12-18 (study day 12.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-02-02 (study day 58.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.